<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7600130</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5844</journal-id>
<journal-id journal-id-type="nlm-ta">Neurosci Lett</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurosci. Lett.</journal-id>
<journal-title-group>
<journal-title>Neuroscience letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">0304-3940</issn>
<issn pub-type="epub">1872-7972</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28242325</article-id>
<article-id pub-id-type="pmc">5470933</article-id>
<article-id pub-id-type="doi">10.1016/j.neulet.2017.02.058</article-id>
<article-id pub-id-type="manuscript">NIHMS859436</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic approaches for the study of PTSD: Advances and challenges</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Banerjee</surname>
<given-names>Sunayana B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrison</surname>
<given-names>Filomene G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ressler</surname>
<given-names>Kerry J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Behavioral Neuroscience and Psychiatric Disorders, Emory University, Atlanta, Georgia 30329, USA</aff>
<aff id="A2"><label>2</label>McLean Hospital, 115 Mill Street, Belmont, MA 02478</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Kerry J. Ressler, M.D Ph.D., James and Patricia Poitras Chair in Psychiatry, Chief, Division of Depression &amp; Anxiety Disorders, McLean Hospital, Professor of Psychiatry, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478, <email>kressler@mclean.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>10</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>5</month>
<year>2018</year>
</pub-date>
<volume>649</volume>
<fpage>139</fpage>
<lpage>146</lpage>
<!--elocation-id from pubmed: 10.1016/j.neulet.2017.02.058-->
<abstract>
<p id="P2">Post-traumatic stress disorder (PTSD) is a highly debilitating stress and anxiety-related disorder that occurs in response to specific trauma or abuse. Genetic risk factors may account for up to 30â€“40% of the heritability of PTSD. Understanding the gene pathways that are associated with PTSD, and how those genes interact with the fear and stress circuitry to mediate risk and resilience for PTSD will enable the development of targeted therapies to prevent the occurrence of or decrease the severity of this complex multi-gene disorder. This review will summarize recent research on genetic approaches to understanding PTSD risk and resilience in human populations, including candidate genes and their epigenetic modifications, genome-wide association studies and neural imaging genetics approaches. Despite challenges faced within this field of study such as inconsistent results and replications, genetic approaches still offer exciting opportunities for the identification and development of novel therapeutic targets and therapies in the future.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>